Munich - Delayed Quote EUR
BioCryst Pharmaceuticals Inc (BO1.MU)
As of 8:00 AM GMT+2. Market Open.
Key Executives
Key Executives Information Not Available
BioCryst Pharmaceuticals Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
BioCryst Pharmaceuticals Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 4, 2024 at 1:30 PM UTC
BioCryst Pharmaceuticals Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
ISI.SG Ionis Pharmaceuticals Inc
35.72
-0.25%
1VT.F Viking Therapeutics, Inc.
60.78
+2.67%
PMRA.F Pharma Mar, S.A.
69.60
+1.61%
AVBP ArriVent BioPharma, Inc.
28.79
+0.28%
ROVI.MC Laboratorios Farmaceuticos Rovi, S.A.
76.90
-0.13%
PHAR Pharming Group N.V.
8.91
-1.00%
CGEM Cullinan Therapeutics, Inc.
16.10
-0.65%
CRIS Curis, Inc.
5.19
-2.65%
VAXX Vaxxinity, Inc.
0.0600
0.00%
IMMP Immutep Limited
1.9350
0.00%